Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics

Respiratory Medicine

Volumn 92, Issue SUPPL. A, 1998, Pages 9-15

  Seale, J P ^a   Harrison, L I ^b  

^a University of Sydney   (Australia)

^b 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; FLUORINATED HYDROCARBON; PROPELLANT;

AREA UNDER THE CURVE; CONFERENCE PAPER; DRUG BIOAVAILABILITY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0031925937     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90212-8     Document Type: Conference Paper

References (9)

1. Alexander DJ, Libretto SE. Overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane). Hum Exp Toxicol 1995; 14: 715-720.
2. Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants-drug deposition and its effect on preclinical and clinical programs. In Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery V Proceedings. Interpharm Press, Buffalo Grove, IL, 1996, pp 133-144.
3. Schultz DW, Carlson S, Ross D. In vitro performance characteristics of two CFC-free metered dose inhalers (MDIs) with large and small volume spacers. Eur Respir J 1996; 9 (Suppl. 23): 255s.
4. Pavord I, Knox A. Pharmacokinetic optimization of inhaled steroid therapy in asthma. Clin Pharmacokinet 1993; 25: 126-135.
5. Harrison LI, Dahl DR, Cline A, et al Pharmacokinetic and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler. Biopharm Drug Dispos 1997; 18: 635-643.
6. Harrison LI, Soria I, Machacek J et al. Multiple dose pharmacokinetics of the extrafine particle size distribution of beclomethasone dipropionate from a CFC-free inhaler. Eur Respir J 1997; 10: 237s.
7. Soria I, Harrison LI, Machacek JH et al. Beclomethasone relative availability of oral beclomethasone dipropionate verses inhaled drug from a HFA-134a metered dose inhaler. Biopharm Drug Dispos 1998; in press.
8. Harrison L, Soria I, Machacek J et al. Pharmacokinetic profile of improved lung delivery with CFC-free ultrafine aerosol steroid inhaler. Am J Respir Crit Care Med 1997; 155: A666.
9. Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 1998; 92 (Suppl. A): 3-8.